[ad_1]
Cutera (NASDAQ:CUTR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports.
According to Zacks, “Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. “
Separately, Piper Sandler boosted their target price on shares of Cutera from $38.00 to $42.00 and gave the company an “overweight” rating in a report on Friday. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Cutera presently has an average rating of “Buy” and a consensus price target of $33.25.
CUTR stock traded up $2.22 during midday trading on Friday, reaching $28.24. 1,570,492 shares of the company’s stock traded hands, compared to its average volume of 232,794. The company has a 50-day moving average price of $30.23 and a two-hundred day moving average price of $22.90. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.48 and a current ratio of 2.13. Cutera has a 52 week low of $9.07 and a 52 week high of $38.80. The firm has a market capitalization of $497.96 million, a PE ratio of -15.60 and a beta of 1.60.
Warren Buffett recently dumped $800 million of Apple stock…
He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…
Cutera (NASDAQ:CUTR) last issued its earnings results on Tuesday, February 16th. The medical device company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.42. Cutera had a negative net margin of 18.83% and a negative return on equity of 61.21%. As a group, analysts predict that Cutera will post -1.76 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nuveen Asset Management LLC grew its position in shares of Cutera by 0.6% during the 4th quarter. Nuveen Asset Management LLC now owns 59,590 shares of the medical device company’s stock valued at $1,437,000 after purchasing an additional 381 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Cutera by 1.2% during the 3rd quarter. Wells Fargo & Company MN now owns 56,944 shares of the medical device company’s stock valued at $1,080,000 after purchasing an additional 654 shares in the last quarter. California State Teachers Retirement System grew its position in shares of Cutera by 3.5% during the 3rd quarter. California State Teachers Retirement System now owns 26,165 shares of the medical device company’s stock valued at $496,000 after purchasing an additional 890 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. grew its position in shares of Cutera by 1.6% during the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 56,064 shares of the medical device company’s stock valued at $1,064,000 after purchasing an additional 900 shares in the last quarter. Finally, State of Tennessee Treasury Department grew its position in shares of Cutera by 24.3% during the 3rd quarter. State of Tennessee Treasury Department now owns 5,852 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 1,145 shares in the last quarter. Hedge funds and other institutional investors own 87.79% of the company’s stock.
Cutera Company Profile
Cutera, Inc, a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women’s intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars.
Featured Article: Asset Allocation Models, Which is Right For You?
Get a free copy of the Zacks research report on Cutera (CUTR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
8 Stocks That Robinhood Investors Got Right
The online investing app Robinhood has been a clear pandemic winner. As more Americans were forced to work from home, many made the decision to begin testing their investing skills by trading stocks. Robinhood appeals to millennial and/or novice investors for several reasons. First, the app makes it fun. You might say it “gamefies” stock trading. With commission-free trades, investors have an incentive to trade frequently. And many users of the app do just that.
The second reason is that it allows investors to buy partial (or fractional) shares. Although Robinhood is often associated with penny stocks, the app lets investors buy shares of “pricey” stocks like Tesla (NASDAQ:TSLA) without having to pay for a full share right away.
And data shows that Robinhood investors have a healthier risk appetite than other investors. And that appetite has increased since the start of the pandemic. This lines up to the time when investors had more time on their hands.
With that said, many Robinhood investors have been, quite frankly, using the app to engage in a legal form of gambling. I say this because trying to dive quickly in and out of the market in an attempt to capture a profit may work. But historically, it’s a path to ruin.
However there are two sides to every story. And the same is true of Robinhood investors. There are many examples of where these investors have gotten it right. In this presentation, we’ll show you eight examples of stocks that the market and Robinhood investors have gotten exactly right.
[ad_2]
Source link